NLRP3 inflammasomes, therefore, leads to multiple faces of MDS pathogenesis—ineffective hematopoiesis, cytopenias, and β-catenin induced proliferation of cancer cells. The gene discussed is NLRP3; the disease is myelodysplastic syndrome.